CARDIEX LIMITED - Announcements

11.1%

3.2¢

Market Cap $17.60M

Technology Scientific & Technical Instruments

CardieX Limited is an Australia-based digital health technology company. The Company... CardieX Limited is an Australia-based digital health technology company. The Company develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

CDX	Underwritten Rights Issue Prospectus Lodged with ASIC	PRICE SENSITIVE	23/04/18	1.05MB	Share
CDX	Oversubscribed Capital Raising to Fast Track New Strategy	PRICE SENSITIVE	23/04/18	115.28KB	Share
CDX	Trading Halt	PRICE SENSITIVE	19/04/18	430.92KB	Share
CDX	Final Director's Interest Notice - D Brookes		05/04/18	391.95KB	Share
CDX	Change to Board of Directors		03/04/18	70.12KB	Share
CDX	Investor Presentation		14/03/18	16.98MB	Share
CDX	AtCor Announces First Steps in Major Strategic Repositioning	PRICE SENSITIVE	14/03/18	80.82KB	Share
CDX	Resignation of CFO/Company Secretary		06/03/18	100.24KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/18	2.21MB	Share
CDX	AtCor's XCEL device clinically validated in 3rd party study	PRICE SENSITIVE	23/01/18	106.01KB	Share
CDX	AtCor and PhysioAge Systems announce supply agreement	PRICE SENSITIVE	11/01/18	149.46KB	Share
CDX	Becoming a substantial holder		22/12/17	1.33MB	Share
CDX	Final Director's Interest Notice		21/12/17	132.16KB	Share
CDX	Initial Director's Interest Notice		21/12/17	131.03KB	Share
CDX	Appointment of Niall Cairns as Non-Executive Director		20/12/17	136.08KB	Share
CDX	AtCor secures $1.0 million new pharmaceutical trial contract	PRICE SENSITIVE	15/12/17	115.97KB	Share
CDX	Initial Director's Interest Notice		05/12/17	127.72KB	Share
CDX	Final Director's Interest Notice		05/12/17	133.04KB	Share
CDX	AtCor appoints Craig Cooper as CEO	PRICE SENSITIVE	30/11/17	105KB	Share
CDX	Results of Meeting		30/11/17	59.85KB	Share
CDX	Chairman's address to 2017 AGM	PRICE SENSITIVE	30/11/17	77.14KB	Share
CDX	Craig Cooper to join AtCor board		15/11/17	50.93KB	Share
CDX	Tax Refund	PRICE SENSITIVE	30/10/17	128.71KB	Share
CDX	Appendix 4G/Corporate Governance Statement		27/10/17	253.49KB	Share
CDX	Annual Report to shareholders		27/10/17	7.19MB	Share
CDX	Notice of Annual General Meeting/Proxy Form		27/10/17	1.11MB	Share
CDX	Change of Director's Interest Notice x 3		29/09/17	103.7KB	Share
CDX	Appendix 3B		22/09/17	102.33KB	Share
CDX	Completion of Share Purchase Plan		22/09/17	77.25KB	Share
CDX	Viking Yacht Company adds SphygmoCor for Employee Wellness		14/09/17	78.98KB	Share
CDX	Security Purchase Plan	PRICE SENSITIVE	08/09/17	142.89KB	Share
CDX	Full Year Statutory Accounts	PRICE SENSITIVE	31/08/17	741.65KB	Share
CDX	Share Purchase Plan	PRICE SENSITIVE	29/08/17	115.47KB	Share
CDX	Cleansing Notice		16/08/17	94.97KB	Share
CDX	Appendix 3B		15/08/17	158.76KB	Share
CDX	Share Placement	PRICE SENSITIVE	08/08/17	141.42KB	Share
CDX	Trading Halt	PRICE SENSITIVE	04/08/17	181.51KB	Share
CDX	AtCor restructures operations	PRICE SENSITIVE	02/08/17	235.55KB	Share
CDX	AtCor Signs New Agreement	PRICE SENSITIVE	31/07/17	244.69KB	Share
CDX	Secures $0.8 million new pharmaceutical trials contracts	PRICE SENSITIVE	12/07/17	228.83KB	Share
CDX	AtCor Signs New Network Health Systems Agreement	PRICE SENSITIVE	07/06/17	220.17KB	Share
CDX	Business update and Strategic Review	PRICE SENSITIVE	18/05/17	235.78KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/17	491.4KB	Share
CDX	AtCor Signs Local Health System Agreement	PRICE SENSITIVE	23/02/17	102.76KB	Share
CDX	Study Finds Central Aortic Waveform Improves HF Treatment	PRICE SENSITIVE	16/02/17	106.01KB	Share
CDX	Tax refund	PRICE SENSITIVE	14/02/17	128.7KB	Share
CDX	Central Blood Pressure Associated with Cognitive Decline		25/01/17	139.22KB	Share
CDX	Positive Novartis drug trial using SphygmoCor XCEL	PRICE SENSITIVE	23/01/17	142.94KB	Share
CDX	Change of Director's Interest Notice x 3		23/12/16	322.7KB	Share
CDX	Appendix 3B		23/12/16	148.8KB	Share
CDX	Results of Meeting		21/12/16	87.71KB	Share
CDX	Cleansing Notice		22/11/16	137.71KB	Share
CDX	Appendix 3B		22/11/16	149.17KB	Share
CDX	Notice of General Meeting/Proxy Form		18/11/16	271.18KB	Share
CDX	AtCor completes share placement	PRICE SENSITIVE	16/11/16	81.47KB	Share
CDX	Trading Halt	PRICE SENSITIVE	14/11/16	217.88KB	Share
CDX	Leading research team highlights role of SphygmoCor	PRICE SENSITIVE	04/11/16	107.1KB	Share
CDX	Results of Meeting-ACG.AX		28/10/16	83.88KB	Share
CDX	Chairmans address to AGM-ACG.AX		28/10/16	94.24KB	Share
CDX	Investor presentation-ACG.AX		25/10/16	815.42KB	Share
CDX	Change of Director's Interest Notice-ACG.AX		24/10/16	146.55KB	Share
CDX	Appendix 3B - option exercise-ACG.AX		24/10/16	148.73KB	Share
CDX	AtCor wins Frost & Sullivan's 2016 Diagnostic Devices award-ACG.AX		18/10/16	107.19KB	Share
CDX	Ceasing to be a substantial holder from AEF,AEF-ACG.AX		30/09/16	242.3KB	Share
CDX	Change in substantial holder from AEF,AEF-ACG.AX		28/09/16	350.67KB	Share
CDX	Appendix 4G/Corporate Governance statement-ACG.AX		26/09/16	275.08KB	Share
CDX	Annual Report to shareholders-ACG.AX		26/09/16	10.8MB	Share
CDX	Notice of Annual General Meeting/Proxy Form-ACG.AX		26/09/16	204.37KB	Share
CDX	AtCor launches key opinion leader webinar series-ACG.AX		26/09/16	109.41KB	Share
CDX	FY2016 results-ACG.AX	PRICE SENSITIVE	30/08/16	127.91KB	Share
CDX	Full Year Statutory Accounts-ACG.AX	PRICE SENSITIVE	30/08/16	578.81KB	Share
CDX	CEO presentation to BioShares Conference-ACG.AX		29/07/16	370.37KB	Share
CDX	Appendix 3B-ACG.AX		21/07/16	148.51KB	Share
CDX	Large national plan to reimburse SphygmoCor test-ACG.AX	PRICE SENSITIVE	07/07/16	90.09KB	Share
CDX	$0.6 million pharmaceutical trial extension-ACG.AX	PRICE SENSITIVE	29/06/16	37.01KB	Share
CDX	Change of Director's Interest Notice-ACG.AX		21/06/16	69.13KB	Share
CDX	Appendix 3B-ACG.AX		21/06/16	133.78KB	Share
CDX	Investor Presentation-ACG.AX		02/05/16	796.47KB	Share
CDX	Tax refund	PRICE SENSITIVE	14/03/16	24.96KB	Share
CDX	Patent granted in USA	PRICE SENSITIVE	09/03/16	36.82KB	Share
CDX	FDA clearance for Oscar 2 with SphygmoCor inside	PRICE SENSITIVE	03/03/16	50.95KB	Share
CDX	CPT-1 Reimbursement Update	PRICE SENSITIVE	29/02/16	39KB	Share
CDX	Appendix 3B		17/02/16	133.73KB	Share
CDX	Patent granted in Japan	PRICE SENSITIVE	17/02/16	36.79KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	12/02/16	285.08KB	Share
CDX	Appendix 3B		11/02/16	133.75KB	Share
CDX	US$0.6m new pharmaceutical trial contract	PRICE SENSITIVE	05/02/16	39.54KB	Share
CDX	Appendix 3B		02/02/16	133.87KB	Share
CDX	Appendix 3B		22/01/16	134.23KB	Share
CDX	Market update	PRICE SENSITIVE	08/01/16	30.13KB	Share
CDX	AtCor and A&D sign multiyear distribution contract for Japan	PRICE SENSITIVE	16/12/15	50.87KB	Share
CDX	Renal Physicians Association and CPT code communication		24/11/15	45.33KB	Share
CDX	Change of Director's Interest Notice x 4		18/11/15	121.5KB	Share
CDX	Final Director's Interest Notice		18/11/15	59.84KB	Share
CDX	Initial Director's Interest Notice		18/11/15	61.93KB	Share
CDX	Results of Meeting		13/11/15	38.34KB	Share
CDX	Chairman's Address to Shareholders		13/11/15	55.52KB	Share
CDX	Investor presentation		06/11/15	619.95KB	Share
CDX	Change in substantial holding from AEF		05/11/15	362.79KB	Share
CDX	US Medicare payment for new category 1 code announced	PRICE SENSITIVE	02/11/15	30.54KB	Share

CDX Underwritten Rights Issue Prospectus Lodged with ASIC
23/04/18	PRICE SENSITIVE	1.05MB	Share
CDX Oversubscribed Capital Raising to Fast Track New Strategy
23/04/18	PRICE SENSITIVE	115.28KB	Share
CDX Trading Halt
19/04/18	PRICE SENSITIVE	430.92KB	Share
CDX Final Director's Interest Notice - D Brookes
05/04/18		391.95KB	Share
CDX Change to Board of Directors
03/04/18		70.12KB	Share
CDX Investor Presentation
14/03/18		16.98MB	Share
CDX AtCor Announces First Steps in Major Strategic Repositioning
14/03/18	PRICE SENSITIVE	80.82KB	Share
CDX Resignation of CFO/Company Secretary
06/03/18		100.24KB	Share
CDX Half Yearly Report and Accounts
28/02/18	PRICE SENSITIVE	2.21MB	Share
CDX AtCor's XCEL device clinically validated in 3rd party study
23/01/18	PRICE SENSITIVE	106.01KB	Share
CDX AtCor and PhysioAge Systems announce supply agreement
11/01/18	PRICE SENSITIVE	149.46KB	Share
CDX Becoming a substantial holder
22/12/17		1.33MB	Share
CDX Final Director's Interest Notice
21/12/17		132.16KB	Share
CDX Initial Director's Interest Notice
21/12/17		131.03KB	Share
CDX Appointment of Niall Cairns as Non-Executive Director
20/12/17		136.08KB	Share
CDX AtCor secures $1.0 million new pharmaceutical trial contract
15/12/17	PRICE SENSITIVE	115.97KB	Share
CDX Initial Director's Interest Notice
05/12/17		127.72KB	Share
CDX Final Director's Interest Notice
05/12/17		133.04KB	Share
CDX AtCor appoints Craig Cooper as CEO
30/11/17	PRICE SENSITIVE	105KB	Share
CDX Results of Meeting
30/11/17		59.85KB	Share
CDX Chairman's address to 2017 AGM
30/11/17	PRICE SENSITIVE	77.14KB	Share
CDX Craig Cooper to join AtCor board
15/11/17		50.93KB	Share
CDX Tax Refund
30/10/17	PRICE SENSITIVE	128.71KB	Share
CDX Appendix 4G/Corporate Governance Statement
27/10/17		253.49KB	Share
CDX Annual Report to shareholders
27/10/17		7.19MB	Share
CDX Notice of Annual General Meeting/Proxy Form
27/10/17		1.11MB	Share
CDX Change of Director's Interest Notice x 3
29/09/17		103.7KB	Share
CDX Appendix 3B
22/09/17		102.33KB	Share
CDX Completion of Share Purchase Plan
22/09/17		77.25KB	Share
CDX Viking Yacht Company adds SphygmoCor for Employee Wellness
14/09/17		78.98KB	Share
CDX Security Purchase Plan
08/09/17	PRICE SENSITIVE	142.89KB	Share
CDX Full Year Statutory Accounts
31/08/17	PRICE SENSITIVE	741.65KB	Share
CDX Share Purchase Plan
29/08/17	PRICE SENSITIVE	115.47KB	Share
CDX Cleansing Notice
16/08/17		94.97KB	Share
CDX Appendix 3B
15/08/17		158.76KB	Share
CDX Share Placement
08/08/17	PRICE SENSITIVE	141.42KB	Share
CDX Trading Halt
04/08/17	PRICE SENSITIVE	181.51KB	Share
CDX AtCor restructures operations
02/08/17	PRICE SENSITIVE	235.55KB	Share
CDX AtCor Signs New Agreement
31/07/17	PRICE SENSITIVE	244.69KB	Share
CDX Secures $0.8 million new pharmaceutical trials contracts
12/07/17	PRICE SENSITIVE	228.83KB	Share
CDX AtCor Signs New Network Health Systems Agreement
07/06/17	PRICE SENSITIVE	220.17KB	Share
CDX Business update and Strategic Review
18/05/17	PRICE SENSITIVE	235.78KB	Share
CDX Half Yearly Report and Accounts
24/02/17	PRICE SENSITIVE	491.4KB	Share
CDX AtCor Signs Local Health System Agreement
23/02/17	PRICE SENSITIVE	102.76KB	Share
CDX Study Finds Central Aortic Waveform Improves HF Treatment
16/02/17	PRICE SENSITIVE	106.01KB	Share
CDX Tax refund
14/02/17	PRICE SENSITIVE	128.7KB	Share
CDX Central Blood Pressure Associated with Cognitive Decline
25/01/17		139.22KB	Share
CDX Positive Novartis drug trial using SphygmoCor XCEL
23/01/17	PRICE SENSITIVE	142.94KB	Share
CDX Change of Director's Interest Notice x 3
23/12/16		322.7KB	Share
CDX Appendix 3B
23/12/16		148.8KB	Share
CDX Results of Meeting
21/12/16		87.71KB	Share
CDX Cleansing Notice
22/11/16		137.71KB	Share
CDX Appendix 3B
22/11/16		149.17KB	Share
CDX Notice of General Meeting/Proxy Form
18/11/16		271.18KB	Share
CDX AtCor completes share placement
16/11/16	PRICE SENSITIVE	81.47KB	Share
CDX Trading Halt
14/11/16	PRICE SENSITIVE	217.88KB	Share
CDX Leading research team highlights role of SphygmoCor
04/11/16	PRICE SENSITIVE	107.1KB	Share
CDX Results of Meeting-ACG.AX
28/10/16		83.88KB	Share
CDX Chairmans address to AGM-ACG.AX
28/10/16		94.24KB	Share
CDX Investor presentation-ACG.AX
25/10/16		815.42KB	Share
CDX Change of Director's Interest Notice-ACG.AX
24/10/16		146.55KB	Share
CDX Appendix 3B - option exercise-ACG.AX
24/10/16		148.73KB	Share
CDX AtCor wins Frost & Sullivan's 2016 Diagnostic Devices award-ACG.AX
18/10/16		107.19KB	Share
CDX Ceasing to be a substantial holder from AEF,AEF-ACG.AX
30/09/16		242.3KB	Share
CDX Change in substantial holder from AEF,AEF-ACG.AX
28/09/16		350.67KB	Share
CDX Appendix 4G/Corporate Governance statement-ACG.AX
26/09/16		275.08KB	Share
CDX Annual Report to shareholders-ACG.AX
26/09/16		10.8MB	Share
CDX Notice of Annual General Meeting/Proxy Form-ACG.AX
26/09/16		204.37KB	Share
CDX AtCor launches key opinion leader webinar series-ACG.AX
26/09/16		109.41KB	Share
CDX FY2016 results-ACG.AX
30/08/16	PRICE SENSITIVE	127.91KB	Share
CDX Full Year Statutory Accounts-ACG.AX
30/08/16	PRICE SENSITIVE	578.81KB	Share
CDX CEO presentation to BioShares Conference-ACG.AX
29/07/16		370.37KB	Share
CDX Appendix 3B-ACG.AX
21/07/16		148.51KB	Share
CDX Large national plan to reimburse SphygmoCor test-ACG.AX
07/07/16	PRICE SENSITIVE	90.09KB	Share
CDX $0.6 million pharmaceutical trial extension-ACG.AX
29/06/16	PRICE SENSITIVE	37.01KB	Share
CDX Change of Director's Interest Notice-ACG.AX
21/06/16		69.13KB	Share
CDX Appendix 3B-ACG.AX
21/06/16		133.78KB	Share
CDX Investor Presentation-ACG.AX
02/05/16		796.47KB	Share
CDX Tax refund
14/03/16	PRICE SENSITIVE	24.96KB	Share
CDX Patent granted in USA
09/03/16	PRICE SENSITIVE	36.82KB	Share
CDX FDA clearance for Oscar 2 with SphygmoCor inside
03/03/16	PRICE SENSITIVE	50.95KB	Share
CDX CPT-1 Reimbursement Update
29/02/16	PRICE SENSITIVE	39KB	Share
CDX Appendix 3B
17/02/16		133.73KB	Share
CDX Patent granted in Japan
17/02/16	PRICE SENSITIVE	36.79KB	Share
CDX Half Yearly Report and Accounts
12/02/16	PRICE SENSITIVE	285.08KB	Share
CDX Appendix 3B
11/02/16		133.75KB	Share
CDX US$0.6m new pharmaceutical trial contract
05/02/16	PRICE SENSITIVE	39.54KB	Share
CDX Appendix 3B
02/02/16		133.87KB	Share
CDX Appendix 3B
22/01/16		134.23KB	Share
CDX Market update
08/01/16	PRICE SENSITIVE	30.13KB	Share
CDX AtCor and A&D sign multiyear distribution contract for Japan
16/12/15	PRICE SENSITIVE	50.87KB	Share
CDX Renal Physicians Association and CPT code communication
24/11/15		45.33KB	Share
CDX Change of Director's Interest Notice x 4
18/11/15		121.5KB	Share
CDX Final Director's Interest Notice
18/11/15		59.84KB	Share
CDX Initial Director's Interest Notice
18/11/15		61.93KB	Share
CDX Results of Meeting
13/11/15		38.34KB	Share
CDX Chairman's Address to Shareholders
13/11/15		55.52KB	Share
CDX Investor presentation
06/11/15		619.95KB	Share
CDX Change in substantial holding from AEF
05/11/15		362.79KB	Share
CDX US Medicare payment for new category 1 code announced
02/11/15	PRICE SENSITIVE	30.54KB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.2¢		Change -0.004(11.1%)		Mkt cap ! $17.60M

Open	High	Low	Value	Volume
3.2¢	3.2¢	3.2¢	$6.593K	206.0K

Buyers (Bids)

No.	Vol.	Price($)
2	195000	3.1¢

Sellers (Offers)

Price($)	Vol.	No.
3.3¢	100000	1

View Market Depth

No.	Vol.	Price($)
2	195000	0.031
7	672138	0.030
1	75000	0.029
2	275000	0.028
2	325000	0.027

Price($)	Vol.	No.
0.033	100000	1
0.034	100000	1
0.036	71197	1
0.037	500000	1
0.038	580000	1

Last trade - 13.09pm 11/08/2025 (20 minute delay)


Last 3.3¢		Change -0.004 ( 0.00 %)
Open	High	Low	Volume
3.3¢	3.3¢	3.1¢	176075
Last updated 15.03pm 11/08/2025 ?

CDX (ASX) Chart

CARDIEX LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories